P And G Hygiene And Health Care Share Price
Sector: Personal & Household Prods.
13245.00 -172.80 (-1.29%)
- 1D
- 5D
- 1M
- 3M
- 6M
- 1Y
- 5Y
- MAX
Price Range
Today’s Low
13153.00
Today’s High
13506.70
52 Week Low
12140.15
52 Week High
17747.85
13220.00 -201.00 (-1.50%)
- 1D
- 5D
- 1M
- 3M
- 6M
- 1Y
- 5Y
- MAX
Price Range
Today’s Low
13150.00
Today’s High
13491.00
52 Week Low
12105.60
52 Week High
17745.00
Key Metrics
- Market Cap (In Cr) 42994.24
- Beta 0.47
- Div. Yield (%) 2.01
- P/B 56.22
- TTM P/E 61.52
- Peg Ratio 51.68
- Sector P/E 45.11
- D/E 0
- Open Price 13411.8
- Prev Close 13417.8
P And G Hygiene And Health Care Analysis
Price Analysis
-
1 Week-0.14%
-
3 Months4.93%
-
6 Month-9.17%
-
YTD-8.79%
-
1 Year-16.32%
Risk Meter
- 22% Low risk
- 22% Moderate risk
- 22% Balanced Risk
- 22% High risk
- 22% Extreme risk
Recos
- Strong Sell
- Sell
- Hold
- Buy
- Strong Buy
Analysts' Views
- Ratings
- Current
- 1 W Ago
- 1 M Ago
- 3 M Ago
- Strong Buy
- 1
- 1
- 1
- 2
- Buy
- 0.00
- 0.00
- 0.00
- 0.00
- Hold
- 1
- 1
- 1
- 1
- Sell
- 0.00
- 0.00
- 0.00
- 0.00
- Strong Sell
- 0.00
- 0.00
- 0.00
- 0.00
- Total
- 2
- 2
- 2
- 3
P And G Hygiene And Health Care News
P&G Hygiene sees rebound in rural demand, but urban stress persists
3 min read . 12 Jun 2025Q4 results today: LIC, Info Edge, Minda Corp, Supriya Lifesciences, Bosch, more
2 min read . 27 May 2025Five fundamentally strong FMCG stocks are down 30% from 52-week highs
8 min read . 23 Jan 2025P And G Hygiene And Health Care Financials
- INCOME
- BALANCE SHEET
- Cashflow
- Period
- 2024
- Total Revenue
- 4205.7
- Selling/ General/ Admin Expenses Total
- 1090.73
- Depreciation/ Amortization
- 56.5
- Other Operating Expenses Total
- 70.17
- Total Operating Expense
- 3282.7
- Operating Income
- 923
- Net Income Before Taxes
- 939.2
- Net Income
- 675.02
- Diluted Normalized EPS
- 212.06
- Period
- 2024
- Total Assets
- 1858.56
- Total Liabilities
- 1083.7
- Total Equity
- 774.86
- Tangible Book Valueper Share Common Eq
- 238.71
- Period
- 2024
- Cashfrom Operating Activities
- 470.53
- Cashfrom Investing Activities
- 1.06
- Cashfrom Financing Activities
- -861.75
- Net Changein Cash
- -390.16
- Period
- 2023
- Total Revenue
- 3917.9
- Selling/ General/ Admin Expenses Total
- 893.31
- Depreciation/ Amortization
- 58.36
- Other Operating Expenses Total
- 96.52
- Total Operating Expense
- 3102.43
- Operating Income
- 815.47
- Net Income Before Taxes
- 839.47
- Net Income
- 678.14
- Diluted Normalized EPS
- 211.35
- Period
- 2023
- Total Assets
- 2137.32
- Total Liabilities
- 1191.29
- Total Equity
- 946.03
- Tangible Book Valueper Share Common Eq
- 291.44
- Period
- 2023
- Cashfrom Operating Activities
- 825.77
- Cashfrom Investing Activities
- -9.91
- Cashfrom Financing Activities
- -477.01
- Net Changein Cash
- 338.85
- Period
- 2022
- Total Revenue
- 3900.92
- Selling/ General/ Admin Expenses Total
- 960.76
- Depreciation/ Amortization
- 52.88
- Other Operating Expenses Total
- 76.3
- Total Operating Expense
- 3115.14
- Operating Income
- 785.78
- Net Income Before Taxes
- 790.14
- Net Income
- 575.75
- Diluted Normalized EPS
- 179.71
- Period
- 2022
- Total Assets
- 1682.57
- Total Liabilities
- 945
- Total Equity
- 737.57
- Tangible Book Valueper Share Common Eq
- 227.22
- Period
- 2022
- Cashfrom Operating Activities
- 573.1
- Cashfrom Investing Activities
- -26.85
- Cashfrom Financing Activities
- -568.94
- Net Changein Cash
- -22.69
- Period
- 2021
- Total Revenue
- 3574.14
- Selling/ General/ Admin Expenses Total
- 935.28
- Depreciation/ Amortization
- 47.66
- Other Operating Expenses Total
- 84.43
- Total Operating Expense
- 2734.58
- Operating Income
- 839.56
- Net Income Before Taxes
- 869.89
- Net Income
- 651.79
- Diluted Normalized EPS
- 205.45
- Period
- 2021
- Total Assets
- 1632.71
- Total Liabilities
- 918.44
- Total Equity
- 714.27
- Tangible Book Valueper Share Common Eq
- 220.04
- Period
- 2021
- Cashfrom Operating Activities
- 863.12
- Cashfrom Investing Activities
- 6.94
- Cashfrom Financing Activities
- -1106.43
- Net Changein Cash
- -236.37
- Period
- 2020
- Total Revenue
- 3001.99
- Selling/ General/ Admin Expenses Total
- 721.06
- Depreciation/ Amortization
- 47.88
- Other Operating Expenses Total
- 70.2
- Total Operating Expense
- 2432.75
- Operating Income
- 569.24
- Net Income Before Taxes
- 593.87
- Net Income
- 433.08
- Diluted Normalized EPS
- 137.11
- Period
- 2020
- Total Assets
- 1828.4
- Total Liabilities
- 670.54
- Total Equity
- 1157.86
- Tangible Book Valueper Share Common Eq
- 356.7
- Period
- 2020
- Cashfrom Operating Activities
- 474.05
- Cashfrom Investing Activities
- 74.72
- Cashfrom Financing Activities
- -190.63
- Net Changein Cash
- 358.14
- Period
- 2019
- Total Revenue
- 2946.85
- Selling/ General/ Admin Expenses Total
- 714.94
- Depreciation/ Amortization
- 49.78
- Other Operating Expenses Total
- 65.85
- Total Operating Expense
- 2380.39
- Operating Income
- 566.46
- Net Income Before Taxes
- 607.33
- Net Income
- 419.13
- Diluted Normalized EPS
- 128.2
- Period
- 2019
- Total Assets
- 1617.04
- Total Liabilities
- 707.98
- Total Equity
- 909.06
- Tangible Book Valueper Share Common Eq
- 280.05
- Period
- 2019
- Cashfrom Operating Activities
- 412.97
- Cashfrom Investing Activities
- 34.32
- Cashfrom Financing Activities
- -313.74
- Net Changein Cash
- 133.55
- Period
- 2025-03-31
- Total Revenue
- 991.63
- Selling/ General/ Admin Expenses Total
- 170.53
- Depreciation/ Amortization
- 10.35
- Other Operating Expenses Total
- 216.72
- Total Operating Expense
- 792.33
- Operating Income
- 199.3
- Net Income Before Taxes
- 212.66
- Net Income
- 156.1
- Diluted Normalized EPS
- 48.09
- Period
- 2025-03-31
- Total Assets
- 1754.73
- Total Liabilities
- 1017.74
- Total Equity
- 736.99
- Tangible Book Valueper Share Common Eq
- 227.04
- Period
- 2025-03-31
- Cashfrom Operating Activities
- 593.21
- Cashfrom Investing Activities
- -34.28
- Cashfrom Financing Activities
- -666.23
- Net Changein Cash
- -107.3
- Period
- 2024-12-31
- Total Revenue
- 1247.63
- Selling/ General/ Admin Expenses Total
- 224.51
- Depreciation/ Amortization
- 9.89
- Other Operating Expenses Total
- 213.04
- Total Operating Expense
- 886.59
- Operating Income
- 361.04
- Net Income Before Taxes
- 364.13
- Net Income
- 268.59
- Diluted Normalized EPS
- 82.74
- Period
- 2024-12-31
- Total Assets
- 2096.95
- Total Liabilities
- 1151.22
- Total Equity
- 945.73
- Tangible Book Valueper Share Common Eq
- 291.35
- Period
- 2024-12-31
- Cashfrom Operating Activities
- 534.68
- Cashfrom Investing Activities
- -25.02
- Cashfrom Financing Activities
- -308.9
- Net Changein Cash
- 200.76
- Period
- 2024-09-30
- Total Revenue
- 1135.16
- Selling/ General/ Admin Expenses Total
- 233.45
- Depreciation/ Amortization
- 11.7
- Other Operating Expenses Total
- 190
- Total Operating Expense
- 856.38
- Operating Income
- 278.78
- Net Income Before Taxes
- 285.37
- Net Income
- 211.9
- Diluted Normalized EPS
- 65.28
- Period
- 2024-09-30
- Period
- 2024-09-30
- Period
- 2024-06-30
- Total Revenue
- 931.75
- Selling/ General/ Admin Expenses Total
- 183.83
- Depreciation/ Amortization
- 13.4
- Other Operating Expenses Total
- 236.25
- Total Operating Expense
- 826.86
- Operating Income
- 104.89
- Net Income Before Taxes
- 112.28
- Net Income
- 81.06
- Diluted Normalized EPS
- 27.87
- Period
- 2024-06-30
- Total Assets
- 1858.56
- Total Liabilities
- 1083.7
- Total Equity
- 774.86
- Tangible Book Valueper Share Common Eq
- 238.71
- Period
- 2024-06-30
- Cashfrom Operating Activities
- 470.53
- Cashfrom Investing Activities
- 1.06
- Cashfrom Financing Activities
- -861.75
- Net Changein Cash
- -390.16
- Period
- 2024-03-31
- Total Revenue
- 1002.17
- Selling/ General/ Admin Expenses Total
- 194.18
- Depreciation/ Amortization
- 14.54
- Other Operating Expenses Total
- 212.92
- Total Operating Expense
- 759.4
- Operating Income
- 242.77
- Net Income Before Taxes
- 233.94
- Net Income
- 154.37
- Diluted Normalized EPS
- 47.56
- Period
- 2024-03-31
- Period
- 2024-03-31
- Period
- 2023-12-31
- Total Revenue
- 1133.43
- Selling/ General/ Admin Expenses Total
- 181.4
- Depreciation/ Amortization
- 14.26
- Other Operating Expenses Total
- 191.32
- Total Operating Expense
- 837.95
- Operating Income
- 295.48
- Net Income Before Taxes
- 308.51
- Net Income
- 228.9
- Diluted Normalized EPS
- 70.51
- Period
- 2023-12-31
- Total Assets
- 2226.52
- Total Liabilities
- 1174.02
- Total Equity
- 1052.5
- Tangible Book Valueper Share Common Eq
- 324.24
- Period
- 2023-12-31
- Cashfrom Operating Activities
- 410.68
- Cashfrom Investing Activities
- -343.92
- Cashfrom Financing Activities
- -342.16
- Net Changein Cash
- -275.4
Forecast
Income Sheet (In Cr)
Net Income Vs Revenue
Returns Metrics (In Cr)
ROA Vs ROE
Forecast
Balance Sheet
Asset vs Liability
Forecast
Cash Flow
Operating vs Investing
P And G Hygiene And Health Care Technical
Moving Average
SMA
- 5 Day13436.85
- 10 Day13413.12
- 20 Day13484.6
- 50 Day13884.92
- 100 Day13853.77
- 300 Day14834.78
P And G Hygiene And Health Care Peers
- Price
- Ratio
- Name
- Latest Price
- Change
- % Change
- 52W High
- 52W Low
- Mkt. Cap
- Dabur India
- 485.5
- 3.75
- 0.78
- 672
- 420.05
- 86112.66
- Colgate Palmolive India
- 2391.7
- 15.6
- 0.66
- 3893
- 2324
- 64944.79
- P And G Hygiene And Health Care
- 13245
- -172.8
- -1.29
- 17747.85
- 12140.15
- 42994.24
- Gillette India
- 10778.5
- -12.3
- -0.11
- 10802.55
- 7169
- 35003.94
- Emami
- 568
- -5.95
- -1.04
- 856.38
- 507.58
- 25047.05
- Name
- P/E (X)
- P/B (X)
- ROE %
- OPM
- Dabur India
- 48.27
- 7.88
- 20.07
- 15.26
- Colgate Palmolive India
- 45.8
- 39.54
- 72.92
- 22.02
- P And G Hygiene And Health Care
- 63.67
- 56.57
- 68.53
- 16.2
- Gillette India
- 81.09
- 35.17
- 36.1
- 14.45
- Emami
- 30.96
- 9.27
- 31.93
- 20.43
P And G Hygiene And Health Care Shareholding
Shareholding Pattern
Shareholding Trend
Shareholding(%) v/s Date
Corporate Actions
- Board Meeting
- AGM
- Dividends
- Bonus
- Split
- Rights
- Meeting Date
- Purpose
- 27-May-25
- Audited Results & Final Dividend
- 11-Feb-25
- Quarterly Results & Interim Dividend
- 30-Oct-24
- Quarterly Results
- 29-Aug-24
- Audited Results & Final Dividend
- 28-Aug-24
- Audited Results & Final Dividend
- 30-Apr-24
- Quarterly Results
- 31-Jan-24
- Quarterly Results & Interim Dividend
- 30-Oct-23
- Quarterly Results
- 28-Aug-23
- Audited Results & Final Dividend
- 10-May-23
- Quarterly Results
- Meeting Date
- Announced on
- Purpose
- 26-Aug-25
- 28-May-25
- AGM
- 26-Nov-24
- 30-Aug-24
- AGM
- 05-Jul-24
- 03-Jun-24
- POM
- 15-Mar-24
- 13-Feb-24
- POM
- 24-Nov-23
- 30-Aug-23
- AGM
- 19-Jul-22
- 17-Jun-22
- POM
- 29-Jun-21
- 27-May-21
- POM
- Announced on
- Record Date
- Ex-Dividend
- Dividend Value
- 27-May-25
- -
- -
- 65
- 31-Jan-25
- 20-Feb-25
- 20-Feb-25
- 110
- 29-Aug-24
- -
- 19-Nov-24
- 95
- 20-Jan-24
- 09-Feb-24
- 09-Feb-24
- 100
- 31-Jan-24
- 09-Feb-24
- 09-Feb-24
- 60
- 28-Aug-23
- -
- 17-Nov-23
- 105
- 10-Jan-23
- 08-Feb-23
- 08-Feb-23
- 80
- 23-Aug-22
- -
- 04-Nov-22
- 65
- 27-Jan-22
- 09-Feb-22
- 08-Feb-22
- 95
- 25-Aug-21
- -
- 09-Nov-21
- 80


